These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 8138996

  • 1. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.
    Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL.
    J Virol; 1994 Apr; 68(4):2118-26. PubMed ID: 8138996
    [Abstract] [Full Text] [Related]

  • 2. Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein.
    Ghiasi H, Nesburn AB, Wechsler SL.
    Vaccine; 1996 Feb; 14(2):107-12. PubMed ID: 8852405
    [Abstract] [Full Text] [Related]

  • 3. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
    Ghiasi H, Bahri S, Nesburn AB, Wechsler SL.
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1352-60. PubMed ID: 7775113
    [Abstract] [Full Text] [Related]

  • 4. Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K.
    Ghiasi H, Slanina S, Nesburn AB, Wechsler SL.
    J Virol; 1994 Apr; 68(4):2347-54. PubMed ID: 8139020
    [Abstract] [Full Text] [Related]

  • 5. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge.
    Ghiasi H, Cai S, Slanina S, Nesburn AB, Wechsler SL.
    Antiviral Res; 1995 Oct; 28(2):147-57. PubMed ID: 8585768
    [Abstract] [Full Text] [Related]

  • 6. Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge.
    Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL.
    Virology; 1992 Jun; 188(2):469-76. PubMed ID: 1585630
    [Abstract] [Full Text] [Related]

  • 7. Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
    Gmyrek GB, Filiberti A, Montgomery M, Chitrakar A, Royer DJ, Carr DJJ.
    J Virol; 2020 Nov 23; 94(24):. PubMed ID: 32999018
    [Abstract] [Full Text] [Related]

  • 8. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A, Soleimanjahi H, Bamdad T, Soudi S, Arefeian E, Hashemi SM, Ebtekar M.
    Comp Immunol Microbiol Infect Dis; 2007 Jul 23; 30(4):197-210. PubMed ID: 17335902
    [Abstract] [Full Text] [Related]

  • 9. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
    Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM.
    J Virol; 2008 Jul 23; 82(14):6935-41. PubMed ID: 18480440
    [Abstract] [Full Text] [Related]

  • 10. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD.
    Baghian A, Chouljenko VN, D'Auvergne O, Newman MJ, Baghian S, Kousoulas KG.
    J Med Microbiol; 2002 Apr 23; 51(4):350-357. PubMed ID: 11926742
    [Abstract] [Full Text] [Related]

  • 11. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1.
    Ghiasi H, Wechsler SL, Kaiwar R, Nesburn AB, Hofman FM.
    J Virol; 1995 Jan 23; 69(1):334-40. PubMed ID: 7983727
    [Abstract] [Full Text] [Related]

  • 12. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins.
    Nass PH, Elkins KL, Weir JP.
    J Infect Dis; 1998 Sep 23; 178(3):611-7. PubMed ID: 9728527
    [Abstract] [Full Text] [Related]

  • 13. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
    Peng T, Ponce-de-Leon M, Jiang H, Dubin G, Lubinski JM, Eisenberg RJ, Cohen GH.
    J Virol; 1998 Jan 23; 72(1):65-72. PubMed ID: 9420201
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice.
    Ghiasi H, Hofman FM, Cai S, Perng GC, Nesburn AB, Wechsler SL.
    Vaccine; 1999 Jun 04; 17(20-21):2576-82. PubMed ID: 10418905
    [Abstract] [Full Text] [Related]

  • 15. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM, Huang ZY, Gallagher JR, Lin Y, Lou H, Whitbeck JC, Wald A, Cohen GH, Eisenberg RJ.
    J Virol; 2015 Sep 04; 89(18):9213-31. PubMed ID: 26109729
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants.
    Blacklaws BA, Krishna S, Minson AC, Nash AA.
    Virology; 1990 Aug 04; 177(2):727-36. PubMed ID: 2164732
    [Abstract] [Full Text] [Related]

  • 17. Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines.
    Osorio Y, Cohen J, Ghiasi H.
    Invest Ophthalmol Vis Sci; 2004 Feb 04; 45(2):506-14. PubMed ID: 14744892
    [Abstract] [Full Text] [Related]

  • 18. Corneal macrophage infiltrates following ocular herpes simplex virus type 1 challenge vary in BALB/c mice vaccinated with different vaccines.
    Ghiasi H, Hofman FM, Wallner K, Cai S, Perng G, Nesburn AB, Wechsler SL.
    Vaccine; 2000 Dec 08; 19(9-10):1266-73. PubMed ID: 11137266
    [Abstract] [Full Text] [Related]

  • 19. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL, Lukig ML, Liew FY.
    J Exp Med; 1985 Oct 01; 162(4):1304-18. PubMed ID: 2995536
    [Abstract] [Full Text] [Related]

  • 20. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
    Osorio Y, Ghiasi H.
    J Virol; 2005 Mar 01; 79(6):3297-308. PubMed ID: 15731224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.